Invesco
CLPT icon

Invesco’s ClearPoint Neuro CLPT Stock Holding History

Invesco’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
23,545
+2,400
+11% +$30K ﹤0.01% 3311
2026
Q1 		$192K Buy
21,145
+1,302
+7% +$16.4K ﹤0.01% 3493
2025
Q4 		$271K Sell
19,843
-1,972
-9% -$36.6K ﹤0.01% 3422
2025
Q3 		$475K Buy
21,815
+1,140
+6% +$13.4K ﹤0.01% 3238
2025
Q2 		$247K Buy
+20,675
New +$260K ﹤0.01% 3445
2025
Q1 		– Sell
-247,977
Closed -$3.81M – 3782
2024
Q4 		$3.81M Buy
+247,977
New +$3.21M ﹤0.01% 2382
2024
Q2 		– Sell
-10,179
Closed -$69.2K – 3891
2024
Q1 		$69.2K Sell
10,179
-20
-0.2% -$140 ﹤0.01% 3776
2023
Q4 		$69.3K Sell
10,199
-1,335
-12% -$7.56K ﹤0.01% 3727
2023
Q3 		$57.8K Hold
11,534
– – ﹤0.01% 3785
2023
Q2 		$83.5K Buy
+11,534
New +$98.1K ﹤0.01% 3760
2021
Q4 		– Sell
-12,922
Closed -$229K – 4045
2021
Q3 		$229K Buy
+12,922
New +$242K ﹤0.01% 3753

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Invesco's CLPT Position: Q2 2026 in Review

Invesco increased its ClearPoint Neuro (CLPT) stake by 11% in Q2 2026, buying an estimated $30K and bringing the position to 23,545 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #3311.

Invesco first reported a position in CLPT in Q3 2021 and has held it in 11 quarters since. The position peaked at $3.81M in Q4 2024. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Invesco held 23,545 shares of ClearPoint Neuro worth $420K as of Q2 2026.
  • Invesco bought 2,400 ClearPoint Neuro shares in Q2 2026, an estimated $30K.
  • ClearPoint Neuro made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3311 holding.
  • Invesco first reported a position in ClearPoint Neuro in Q3 2021 and has held it in 11 quarters since.
  • Invesco's ClearPoint Neuro position peaked at $3.81M in Q4 2024.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.